<DOC>
	<DOCNO>NCT01945801</DOCNO>
	<brief_summary>This study evaluate intervention 1 ) sodium-restricted diet , 2 ) diuretic , 3 ) placebo pill treatment obstructive sleep apnea adult .</brief_summary>
	<brief_title>Sodium-Restricted Diet Diuretic Treatment Severe Sleep Apnea</brief_title>
	<detailed_description>Men apnea-hypopnea index great 30/hour include randomly assign three group : sodium-restricted diet , diuretic , control . The intervention last one week . The diuretic group receive combine spironolactone 100mg plus furosemide 20mg daily . The diet group receive regimen maximum intake three gram sodium per day . The control group receive placebo pill maintain eat habit .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>Men age range 18 60 year Fullnight inlaboratory polysomnography apneahypopnea index &gt; 30/h last three month Body mass index &lt; 35 kg/m2 Informed consent Already start treatment sleep apnea , include use continuous positive airway pressure NYHA heart failure , class Predominantly central apnea Peripheral venous lymphatic insufficiency Any chronic renal disease Use diuretic substance action central peripheral nervous system benzodiazepine , hypnotic , anticonvulsant , antidepressant , appetite suppressant , amphetamine , antiparkinson agent , muscle relaxant , bronchodilator Stroke within 6 month incapacitate sequelae Any physical , mental social condition impair ability participate trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Sleep apnea</keyword>
	<keyword>Treatment</keyword>
	<keyword>Sodium-Restricted Diet</keyword>
	<keyword>Diuretic</keyword>
	<keyword>Lasilactone</keyword>
</DOC>